Factors related to poor control of blood pressure with antihypertensive drug therapy

Blood Pressure

Volumn 12, Issue 1, 2003, Pages 49-55

  Jokisalo, Errki ^a   Enlund, Hannes ^b   Halonen, Pirjo ^a   Takala, Jorma ^a   Kumpusalo, Esko ^a,c  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUWAIT UNIVERSITY   (Kuwait)

^c KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Attitude; Drug therapy; Hypertension; Primary healthcare; Treatment outcome

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AGE; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; FACTORIAL ANALYSIS; FEMALE; FRUSTRATION; GENDER; HEALTH CARE; HEALTH CENTER; HUMAN; HYPERTENSION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PATIENT ATTITUDE; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUESTIONNAIRE; STATISTICAL MODEL; TENSION;

AGE FACTORS; AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CROSS-SECTIONAL STUDIES; DATA COLLECTION; FEMALE; FINLAND; HUMANS; HYPERTENSION; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PATIENT COMPLIANCE; PROFESSIONAL-PATIENT RELATIONS; RISK FACTORS; SEX FACTORS; TIME FACTORS;

EID: 0037260802     PISSN: 08037051     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Seshadri S, et al. Elevated midlife blood pressure increases stroke risk in elderly persons. The Framingham study. Arch Intern Med 2001; 161: 2343-50.
2. Miura K, et al. Relationship of blood pressure to 25-year mortality due to coronary heart disease, cardiovascular diseases, and all causes in young adult men. The Chicago Heart Association Detection Project in Industry. Arch Intern Med 2001; 161: 1501-8.
3. Mulrow CD, et al. Hypertension in the elderly. Implications and generalizability of randomized trials. JAMA 1994; 272: 1932-8.
4. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997; 157: 2413-46.
5. Puska P, et al. Changes in premature deaths in Finland: successful long-term prevention of cardiovascular diseases. Bull World Health Organ 1998; 76: 419-25.
6. Vartiainen E, et al. Cardiovascular risk factor changes in Finland, 1972-1997. Int J Epidemiol 2000; 29: 49-56.
7. Kumpusalo E, Pärnänen H, Takata J. Treatment situation of hypertensive patients in Finnish primary health care. Blood Press 1997; 6 Suppl 1: 35-9.
8. Hyman DJ, Pavlik VN. Characteristics of patients with uncontrolled hypertension in the United States. N Engl J Med 2001; 345: 479-86.
9. Enlund H, Jokisalo E, Wallenius S, Korhonen M. Patient-perceived problems, compliance, and the outcome of hypertension treatment. Pharm World Sci 2001; 23: 60-4.
10. Jokisalo E, Kumpusalo E, Enlund H, Takata J. Patients' perceived problems with hypertension and attitudes towards medical treatment. J Hum Hypertens 2001; 15: 755-61.
11. Hosmer DW, Lemeshow S. Applied logistic regression. New York: John Wiley & Sons, 1989: 90-106.
12. Everson SA, Kaplan GA, Goldberg DE, Salonen JT. Hypertension incidence is predicted by high levels of hopelessness in Finnish men. Hypertension 2000; 35: 561-7.
13. Everson SA, et al. Hopelessness and risk of mortality and incidence of myocardial infarction and cancer. Psychosom Med 1996; 58: 113-21.
14. Yakovlevitch M, Black HR. Resistant hypertension in a tertiary care clinic. Arch Intern Med 1991; 151: 1786-92.
15. Fitzmaurice DA, Adams JL. A systematic review of patient information leaflets for hypertension. J Hum Hypertens 2000; 14: 259-62.
16. Knight EL, et al. Predictors of uncontrolled hypertension in ambulatory patients. Hypertension 2001; 38: 809-14.
17. Sandvik E, Steine S. White coat hypertension in a general practice. Prevalence, cardiovascular risk factors and clinical implications. Scand J Prim Health Care 1998; 16: 222-6.
18. Martinez MA, et al. Frequency and determinants of white coat hypertension in mild to moderate hypertension. A primary care-based study. Am J Hypertens 1999; 12: 251-9.
19. Fujii J, Seki A. Compliance and compliance-improving strategies in hypertension: the Japanese experience. J Hypertens 1985; 3 Suppl 1: 19-22.
20. Khalil SA, Elzubier AG. Drug compliance among hypertensive patients in Tabuk, Saudi Arabia. J Hypertens 1997; 15: 561-5.
21. Cramer JA, Scheyer RD, Mattson RH. Compliance declines between clinic visits. Arch Intern Med 1990; 150: 1509-10.
22. Morris LS, Schulz RM. Patient compliance - an overview. J Clin Pharm Ther 1992; 17: 283-95.
23. Jokisalo E, et al. Factors related to non-compliance with antihypertensive drug therapy. J Hum Hypertens 2002; 16: 577-83.
24. Ware JE, Sherbourne CD. The MOS 36-item Short-Form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30: 473-83.